Teleflex Life Sciences II LLC

58 patents currently held · Updated Nov 15, 2026

3 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Dec 2026

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 20, 2026
The maintenance fee for Powered Intraosseous Driver with Protective Member, and Related Kits, Components, and Methods (US 11,678,909) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
2 fees due Jan 7, 2027
1 fee due Feb 28, 2027
The maintenance fee for Drivers and Drive Systems (US 11,737,765) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
2 fees due Apr 3, 2027
1 fee due Oct 19, 2027
The maintenance fee for Apparatus and method for accessing the bone marrow (US 9,314,228) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026
19 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 7,595,429	Calcium Zeolite Hemostatic Agent In force Ends no later than Dec 5, 2026 · Medium confidence	In force	Ends no later than Dec 5, 2026	Medium confidence
US 8,252,344	Partially Hydrated Hemostatic Agent In force Term ends Dec 5, 2026 · Medium confidence	In force	Term ends Dec 5, 2026	Medium confidence
US 7,968,114	Clay-Based Hemostatic Agents and Devices for the Delivery Thereof In force Term ends Dec 19, 2026 · High confidence	In force	Term ends Dec 19, 2026	High confidence
US 12,337,132	Apparatus and Methods to Communicate Fluids And/Or Support Intraosseous Devices In force Term ends Jan 3, 2027 · High confidence	In force	Term ends Jan 3, 2027	High confidence
US 12,076,448	Hemostatic Devices In force Ends no later than Feb 15, 2027 · Low confidence	In force	Ends no later than Feb 15, 2027	Low confidence
US 8,252,318	Devices and Methods for the Delivery of Blood Clotting Materials to Bleeding Wounds In force Term ends Mar 10, 2027 · High confidence	In force	Term ends Mar 10, 2027	High confidence
US 8,715,287	Apparatus and Method to Provide Emergency Access to Bone Marrow In force Term ends Mar 28, 2027 · High confidence	In force	Term ends Mar 28, 2027	High confidence
US 11,426,249	Vertebral Access System and Methods In force Term ends Sep 11, 2027 · Medium confidence	In force	Term ends Sep 11, 2027	Medium confidence
US 9,072,543	Vascular Access Kits and Methods In force Term ends Nov 3, 2027 · High confidence	In force	Term ends Nov 3, 2027	High confidence
US 7,815,642	Impact-Driven Intraosseous Needle In force Term ends Jan 2, 2028 · Medium confidence	In force	Term ends Jan 2, 2028	Medium confidence

10 of 58 patents shown.

Pro members see all 58.

Pro members: see all 58 patents

Also on record, not counted in the 58: 3 patents in force now held by others · 63 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending

List them